|
Determine retroviral transduction efficiency and gene expression in
virtually any target cell line
Versatile Reporter Vectors for Monitoring Viral Transduction
Brenda Rogers • Katherine Felts • Peter Vaillancourt
Stratagene
We describe three new ViraPort™ retroviral reporter vectors: pFB-hrGFP
¨¨¨Y, pFB-Neo-LacZ ±±,¨¨¨,
and pFB-Luc ¨¨¨,
which can be used to determine transduction efficiency and gene expression in
virtually any target cell line. To assay for expression, use simple fluorescence
microscopy or FACS with pFB-hrGFP, carry out a b-galactosidase-activity
assay or in situ staining with pFB-Neo-LacZ, or perform a luciferase activity
assay with pFB-Luc. These control vectors are available as plasmid DNA as well
as transduction-ready, replication-incompetent, VSV-G pseudotyped high-titer
retroviral supernatants. The vectors are particularly useful as controls
when using the ViraPort™ retroviral gene expression systems.
We recently introduced a set of human and rodent ViraPort™
retroviral cDNA expression libraries inserted into the MMLV-based high-titer
retroviral vector pFB1,2. These complex cDNA libraries, part of our
growing collection of ViraPort retroviral premade libraries, are easily and
efficiently introduced into virtually any mitotic cell type for screening based
on gene function. The insert capacity of pFB, our MMLV-based
replication-defective pFB vector, is approximately 8.0 kb because there is no
extraneous sequence between the LTRs. We excluded selectable markers or readily
detectable reporter genes from the ViraPort retroviral gene expression systems
to ensure that the largest cDNAs possible could be inserted.
Dispensing with marker genes eliminates a direct method for measuring the
infectious titer of the resulting retroviral supernatants for a given target
cell line, and expression levels cannot be readily determined for the target of
choice. To counteract this problem, we constructed and validated a set of
high-titer retroviral reporter vectors based on the pFB vector, which can be
used to assess transduction efficiency and readily assay for gene expression in
infected cells lines. These retroviral reporters are available as plasmid DNA as
well as transduction-ready, VSV-G pseudotyped high-titer retroviral
supernatants.
pFB-hrGFP Vector

Fig.1
We recently cloned and humanized the green fluorescent protein from the
sea pansy Renilla reniformis,* (See page 85). Mammalian tissue
culture cells transfected with plasmids harboring the humanized reniformis
green fluorescent protein (hrGFP) downstream of the viral promoter were
bright green (emission peak: 506 nm), which compares to that typically
seen for the humanized, red-shifted A. victoria GFP (EGFP) (data
not shown). The coding sequence for hrGFP was inserted between the EcoR
I and Xho I sites in the pFB vector to produce the pFB-hrGFP vector
(Figure
1A). The vector was then tested in retrovirally transduced cells.
To produce virus, a 293-derived cell line was transiently transfected
with pFB-hrGFP together with the gag-pol and VSV-G env expression vectors
pVPack-GP and pVPack-VSV-G.3 (Figure
1B) Transfections were carried out using the Transfection MBS mammalian
transfection kit (Stratagene), modified according to Pear et. al.4
Figure 2 shows that HeLa cells transduced with the virus were highly fluorescent
and readily detectable by fluorescence microscopy. To determine transduction
efficiencies for the vector, each of five target cell lines were infected
with serially diluted viral supernatant and, after a 2-day expression
period, the transduction efficiency was determined by FACS. Titers were
calculated2,3 for supernatant dilutions that fell within the
linear dose:response range for transduction. Titers in excess of 107
cfu/ml were achieved for four out of the five cell lines tested (Table
1). For experiments in which cells were infected at a low multiplicity
of infection (MOI) and, thus, harbor only single copies of the hrGFP provirus,
fluorescence over background was readily detectable with this vector.
Table 1
Viral Titers* for pFB-hrGFP and pFB-Neo-LacZ vectors
|
Vector
|
Dilution
|
CHO
|
293
|
HeLa
|
COS-7
|
NIH-3T3
|
|
pFB-hrGFP
vector
|
1:103
|
1.4 x 107
|
4.9 x 107
|
2.0 x 107
|
2.0 x 107
|
2.5 x 106
|
|
1:104
|
2.0 x 107
|
6.3 x 107
|
2.4 x 107
|
3.0 x 107
|
2.8 x 106
|
|
pFB-Neo-LacZ
vector
|
1:102
|
5.0 x 106
|
—
|
—
|
—
|
—
|
|
1:103
|
6.0 x 106
|
—
|
—
|
—
|
—
|
|
* Titer = (fraction of cells fluorescing over background) x (supernatant dilution/ml) x (2 x 105 cells infected). Titers for pFB-Neo-LacZ vector = (fraction blue cells / total # cells in field) x (supernatant dilution / ml) x (2 x 105 cells infected); titers represent the average for 3 randomly chosen fields for each dilution.
|

Fig.2
pFB-Neo-LacZ Vector
The use of b-galactosidase as a reporter in retroviral
vectors has a number of advantages over other reporters. The enzymatic
activity of b-galactosidase can be used as
a quantitative measure of gene expression from the viral promoter in a
cell line of choice. In addition, virally transduced cells can be visualized
in situ by staining with X-gal, and viral titers may be determined both
by counting blue cells using light microscopy or by FACS analysis of infected
cells following incubation with a fluorescent b-galactosidase
substrate. Additionally, by employing the pFB-Neo-LacZ vector, viral titers
may also be determined by G418-resistant colony formation due to the presence
of the neo marker downstream of the b-galactosidase
gene in a bicistronic, IRES-containing cassette (Figure
1A).
We first tested the vector by preparing virus (described above) and infecting
CHO cells. Transduced cells were fixed and stained in situ with X-gal
using the In Situ b-Galactosidase Staining
Kit (Stratagene); the resulting transduced cells stained an intense blue
(Figure 2). Viral titers were then determined by counting blue-stained cells
as a percentage of the total number of cells visible in a microscopic
grid. As indicated in Table
1, titers greater than 106 cfu/ml were achieved for CHO
cells (the only cell line tested). In a separate experiment, equivalent
titers were determined in parallel by both X-gal staining and selection
of neomycin-resistant colony formation.2
pFB-Luc Vector

Fig.3
For certain applications in which a rapid and sensitive assessment of
gene expression efficiency from the viral promoter in a target cell of
choice is required, luciferase is the reporter of choice. In Figure
3, NIH-3T3 cells infected with VSV-G pseudotyped virions made using
pFB-Luc at very low MOIs show a dose-responsive luciferase readout. In
addition, they display a significant signal above background at an MOI
of 1:20,000, which represents an infection of 200,000 cells with approximately
10 virus particles.
Conclusions
Use ViraPort retroviral reporter vectors in conjunction with ViraPort
retroviral premade libraries to reveal the efficiency of any retroviral
transduction. When carrying out costly and time-consuming gene delivery
experiments, where gene products are not readily detected and where the
efficiency of infection and gene expression for cell lines is unknown, valuable
information can be determined from using these vectors. These vectors are useful
in the ViraPort retroviral premade libraries. Stratagene offers three different
vectors for the greatest versatility. The standard control vector pFB-Luc is
supplied with each ViraPort retroviral premade library, and the pFB Neo-LacZ and
pFB-hrGFP vectors are available separately.
|
|